Deutsche Bank
INMB icon

Deutsche Bank’s INmune Bio INMB Stock Holding History

Deutsche Bank’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$334 Sell
296
-6,627
-96% -$9.44K ﹤0.01% 3601
2025
Q4 		$10.8K Sell
6,923
-54,789
-89% -$97.8K ﹤0.01% 3547
2025
Q3 		$128K Buy
61,712
+61,416
+20,749% +$141K ﹤0.01% 3257
2025
Q2 		$684 Sell
296
-37,715
-99% -$277K ﹤0.01% 3577
2025
Q1 		$297K Sell
38,011
-71,837
-65% -$570K ﹤0.01% 2763
2024
Q4 		$513K Hold
109,848
– – ﹤0.01% 2600
2024
Q3 		$592K Hold
109,848
– – ﹤0.01% 2369
2024
Q2 		$969K Hold
109,848
– – ﹤0.01% 2013
2024
Q1 		$1.29M Hold
109,848
– – ﹤0.01% 1872
2023
Q4 		$1.24M Hold
109,848
– – ﹤0.01% 1907
2023
Q3 		$744K Sell
109,848
-11,200
-9% -$92.9K ﹤0.01% 1906
2023
Q2 		$1.1M Hold
121,048
– – ﹤0.01% 1939
2023
Q1 		$782K Hold
121,048
– – ﹤0.01% 2241
2022
Q4 		$767K Hold
121,048
– – ﹤0.01% 2215
2022
Q3 		$750K Hold
121,048
– – ﹤0.01% 2145
2022
Q2 		$1.07M Buy
121,048
+15,000
+14% +$112K ﹤0.01% 2136
2022
Q1 		$893K Hold
106,048
– – ﹤0.01% 2423
2021
Q4 		$1.08M Sell
106,048
-8
-0% -$118 ﹤0.01% 2384
2021
Q3 		$2.06M Buy
106,056
+8
+0% +$154 ﹤0.01% 2070
2021
Q2 		$1.86M Hold
106,048
– – ﹤0.01% 2298
2021
Q1 		$1.26M Buy
106,048
+10,000
+10% +$180K ﹤0.01% 2512
2020
Q4 		$1.65M Hold
96,048
– – ﹤0.01% 2066
2020
Q3 		$990K Hold
96,048
– – ﹤0.01% 2199
2020
Q2 		$504K Buy
96,048
+40,000
+71% +$201K ﹤0.01% 2637
2020
Q1 		$187K Buy
56,048
+10,000
+22% +$45.2K ﹤0.01% 2982
2019
Q4 		$267K Buy
46,048
+4,715
+11% +$22.7K ﹤0.01% 3051
2019
Q3 		$243K Buy
41,333
+8,000
+24% +$59.2K ﹤0.01% 3070
2019
Q2 		$324K Hold
33,333
– – ﹤0.01% 3541
2019
Q1 		$261K Buy
+33,333
New +$258K ﹤0.01% 3851

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deutsche Bank's INMB Position: Q1 2026 in Review

Deutsche Bank reduced its INmune Bio (INMB) stake by 96% in Q1 2026, selling an estimated $9.44K and leaving 296 shares worth $334. The position accounts for ﹤0.01% of the portfolio, ranked #3601.

Deutsche Bank first reported a position in INMB in Q1 2019 and has held it in 29 quarters since. The position peaked at $2.06M in Q3 2021. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • Deutsche Bank held 296 shares of INmune Bio worth $334 as of Q1 2026.
  • Deutsche Bank sold 6,627 INmune Bio shares in Q1 2026, an estimated $9.44K.
  • INmune Bio made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #3601 holding.
  • Deutsche Bank first reported a position in INmune Bio in Q1 2019 and has held it in 29 quarters since.
  • Deutsche Bank's INmune Bio position peaked at $2.06M in Q3 2021.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.